Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies.
Bergantini, L
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies. [electronic resource] - Inflammation Apr 2020 - 393-400 p. digital
Publication Type: Journal Article; Review
1573-2576
10.1007/s10753-019-01157-0 doi
Anti-Asthmatic Agents--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Asthma--drug therapy
Daclizumab--administration & dosage
Drug Delivery Systems--methods
Humans
Severity of Illness Index
T-Lymphocytes, Regulatory--immunology
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies. [electronic resource] - Inflammation Apr 2020 - 393-400 p. digital
Publication Type: Journal Article; Review
1573-2576
10.1007/s10753-019-01157-0 doi
Anti-Asthmatic Agents--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Asthma--drug therapy
Daclizumab--administration & dosage
Drug Delivery Systems--methods
Humans
Severity of Illness Index
T-Lymphocytes, Regulatory--immunology